This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
News & Press: General News

Sarah Kennett and Joseph Kutza Elected to CASSS Board of Directors

Wednesday, February 6, 2019   (0 Comments)
Share |

Sarah Kennett and Joseph Kutza Elected to CASSS Board of Directors


Sarah Kennett
Genentech, a Member of the Roche Group


Joseph Kutza
MedImmune, A member of the AstraZeneca Group

CASSS – Sharing Science Solutions is pleased to announce Sarah Kennett and Joseph Kutza have been elected to the Board of Directors.  They will join the twelve-member board responsible for governance and strategic direction of the association.  Sarah and Joe are both honored to be elected to the CASSS Board of Directors. 

 “CASSS was introduced to me by an FDA mentor 12 years ago,” Sarah recalled. “Since then, my participation in CASSS conferences has offered me insight into many aspects of the biopharmaceutical industry, including the opportunity to interact with and share with colleagues from around the globe. It is to further contribute to the strength and reach of CASSS that I look forward to my new role and responsibilities with the board of directors.”

 Joe said, “Through the years of attending and participating in CASSS conferences, it’s been clear to me that this organization is different. CASSS is committed to sharing science solutions and doing so collaboratively with global regulators. As a member of the Board of Directors, I look forward to working across our portfolio to improve our programs and to have our technology and our content grow to meet our goals of global access, knowledge sharing, and regulatory capacity building.”

 Kennett is Technical Regulatory Director for Biologics for Genentech, a Member of the Roche Group. She has a Ph. D in Molecular Cancer Biology from Duke University and a BS in Molecular and Cell Biology with a Minor in Microbiology from The Pennsylvania State University. 

 Kennett has been active on multiple scientific organizing committees at CASSS including North America CMC Strategy Forum (since 2013) and CE Pharm (2008-2015).  She is also involved as an Associate Director (since 2017) which includes an active role in the Stakeholder Engagement Committee at CASSS.   

 Kutza is Director and Group Manager in Regulatory Affairs - CMC at MedImmune, A member of the AstraZeneca Group.  He has a Ph.D in Psychoneuroimmunology from The Medical College of Pennsylvania and a BS in Biology and Minor in Chemistry from Misericordia University. 

 Kutza has been active on multiple scientific organizing committees at CASSS including WCBP (since 2010), North America CMC Strategy Forum (since 2013) and Latin America CMC Strategy Forum (since 2019).  He has also been involved as an Associate Director (since 2011).    

 


Membership Software Powered by YourMembership  ::  Legal